Skip to content

Grape Polyphenols and Second-meal Effect

Potential Modulatory Effect of Whole Grape on Second-meal Tolerance in Obese Subjects: Role of Polyphenols

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03741218
Acronym
GRAPESECOND
Enrollment
25
Registered
2018-11-14
Start date
2018-12-10
Completion date
2020-02-15
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Polyphenols, Obesity, Grape, Postprandial, Insulin resistance, Second meal effect

Brief summary

The aim of this is study is to evaluate the effects of a single intake of grapes (a polyphenol-rich food) in postprandial metabolism in subjects with obesity, including a first intake (high-fat breakfast) after overnight fasting a second one (medium-fat lunch). Studies on the effects of polyphenols on postprandial (glucidic and lipidic) metabolism have commonly been performed in animal models and have used grape extracts, ignoring the whole pool of polyphenols present in grapes (extractable and non-extractable polyphenols). Besides, the contribution of polyphenols to the so-called second-meal effect has not been explored. It should be highlighted that this study aims to explore the potential beneficial role of fresh grapes, consumed as fruit; in order to ensure the stability of the product, they will be provided as freeze-dried milled material, but the amount received by the subjects could be incorporated into a common diet, being equivalent to 300 g of fresh grapes.

Detailed description

Twenty-five subjects with obesity will be were recruited. Detailed inclusion and exclusion criteria are provided below. The subjects will receive, after overnight fasting, either a monodose of freeze-dried grapes (equivalent to 300 g of fresh grapes) or isocaloric placebo solved in water, together with a high-fat breakfast. Blood samples will be collected before the intake, up to 5 h after breakfast, then a medium-fat lunch will be provided and blood samples will be collected for three additional hours. Both interventions will be separated by two weeks. The following determinations will be performed in blood samples collected at different periods: glucose, insulin, triglycerides, uric acid, viscosity, antioxidant capacity. Additionally, a satiety test will be provided. It is expected that grape supplementation, as compared with an isocaloric placebo, causes significant modifications in all the parameters indicated. Nevertheless, the primary outcome of this study is the area under the curve for glucose after the second meal (300-420 min from basal time).

Interventions

OTHERFreeze-dried grape (GRAP)/Placebo (PLA)

The subjects will receive, after overnight fasting, either a monodose of freeze-dried grapes (equivalent to 300 g of fresh grapes) or isocaloric placebo solved in water, together with a high-fat breakfast. Blood samples will be collected before the intake, up to 5 h after breakfast, then a medium-fat lunch will be provided and blood samples will be collected for three additional hours. A total of 10 samples will be collected: 0-30-60-120-180-240-300-330-360-420 min. Both interventions will be separated by two weeks. Subjects will be instructed not to modify their dietary habits during the development of the study, but during the 72 h before each visit they will have to restrict the intake of polyphenol-rich foods (a detailed list will be provided).

Sponsors

California Table Grape Commission
CollaboratorOTHER
National Research Council, Spain
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Caregiver)

Masking description

GRAP and PLA will have the same aspect, so neither the participant and the care provider will know the received treatment at each stage.

Intervention model description

GRAP: dried and milled grape pomaces. PLA: control period. All the subjects will pass the two periods: one half will receive the acute PLA supplementation followed by the acute GRAP supplementation, and the other half will do it inversely. The assignment to each order will be done randomly. Both period will be separated by a two weeks washing period.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Obesity (BMI = 30-40 kg/m2).

Exclusion criteria

* Subjects with a pharmaceutical treatment set to modify blood pressure, lipid profile or glucose. * Subjects with diagnoses of type 2 diabetes, cardiovascular diseases or thyroid diseases. * Values above the following ones: glucose, \> 115 mg/dL; triglycerides, \> 350 mg/dL; total cholesterol, \> 280 mg/dL; systolic blood pressure, \> 150 mmHg; diastolic blood pressure, \> 100 mmHg * Previous bariatric surgery. * Volunteers participating in other studies (currently or during last year) or weight loss plans. * Pregnant or breastfeeding women. * Adherence to vegetarian diets or usual consumption of dietary supplements.

Design outcomes

Primary

MeasureTime frameDescription
Postprandial glucose (300-420 min)Up to two monthsChanges of postprandial blood glucose as result of supplementation with grapes, measured area under the curve for the period 300-420 min

Other

MeasureTime frameDescription
Plasma triglyceridesUp to four monthsChanges of plasma triglycerides (0-300 and 300-420 min) as result of supplementation with grapes
Plasma uric acidUp to four monthsChanges of plasma uric acid (0-300 and 300-420 min) as result of supplementation with grapes
Postprandial glucose and insulinUp to four monthsChanges of blood glucose (0-320 min) and insulin (0-300 and 300-420 min) as result of supplementation with grapes
Plasma viscosityUp to six monthsChanges of plasma viscosity (0-300 and 300-420 min) as result of supplementation with grapes.
SatietyUp to three monthsChanges of satiety (0-300 and 300-420 min) as result of supplementation with grapes.
Plasma antioxidant capacityUp to five monthsChanges of plasma antioxidant capacity (0-300 and 300-420 min) as result of supplementation with grapes

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026